Brain imaging in patients with diabetes: A systematic review

Diabetes Care

Volumn 29, Issue 11, 2006, Pages 2539-2548

  Van Harten, Barbera ^a,b,e   De Leeuw, Frank Erik ^c   Weinstein, Henry C ^a,b   Scheltens, Philip ^b   Biessels, Geert Jan ^d  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ATROPHY; BRAIN DAMAGE; BRAIN INFARCTION; BRAIN RADIOGRAPHY; BRAIN VENTRICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; WHITE MATTER;

BRAIN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845480120     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1637     Document Type: Review

References (69)

1. Allen KV, Frier BM, Strachan MW: The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 490:169-175, 2004
2. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P: Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64-74, 2006
3. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP: The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726-735, 2005
4. Stewart R, Liolitsa D: Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16:93-112, 1999
5. Strachan MW, Deary IJ, Ewing FM, Frier BM: Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20:438-445, 1997
6. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH: Ageing and diabetes: implications for brain function. Eur J Pharmacol 441:1-14, 2002
7. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke 27:1274-1282, 1996
8. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM: Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 33:21-25, 2002
9. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, DeCarli C: Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 35:1857-1861, 2004
10. Manolio TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Gardin JM, Fried LP, Steinberg EP, Bryan RN: Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke 25:318-327, 1994
11. Biessels GJ, Koffeman A, Scheltens P: Diabetes and cognitive impairment: clinical diagnosis and brain imaging in patients attending a memory clinic. J Neurol 253:477-482, 2006
12. den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, Breteler MM: Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46:1604-1610, 2003
13. Schmidt R, Launer LJ, Nilsson LG, Pajak A, Sans S, Berger K, Breteler MM, de Ridder M, Dufouil C, Fuhrer R, Giampaoli S, Hofman A: Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) study. Diabetes 53:687-692, 2004
14. Taylor WD, MacFall JR, Payne ME, McQuoid DR, Steffens DC, Provenzale JM, Krishnan RR: Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res 139:1-7, 2005
15. Jorm AF, Anstey KJ, Christensen H, de Plater G, Kumar R, Wen W, Sachdev P: MRI hyperintensities and depressive symptoms in a community sample of individuals 60-64 years old. Am J Psychiatry 162:699-705, 2005
16. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH: Evidence for diabetic encephalopathy. Diabet Med 8:162-167, 1991
17. Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K, Payer F, Freidl W, Niederkorn K, Lechner H: Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. Arch Neurol 49:825-827, 1992
18. Streifler JY, Eliasziw M, Benavente OR, Alamowitch S, Fox AJ, Hachinski V, Barnett HJ: Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke 34:1913-1916, 2003
19. Hijdra A, Verbeeten B Jr, Verhulst JA: Relation of leukoaraiosis to lesion type in stroke patients. Stroke 21:890-894, 1990
20. Lazarus R, Prettyman R, Cherryman G: White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders. Int J Geriatr Psychiatry 20:274-279, 2005
21. Araki Y, Nomura M, Tanaka H, Yamamoto H, Yamamoto T, Tsukaguchi I, Nakamura H: MRI of the brain in diabetes mellitus. Neuroradiology 36:101-103, 1994
22. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S: Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 28:1932-1939, 1997
23. Masana Y, Motozaki T: Emergence and progress of white matter lesion in brain check-up. Acta Neurol Scand 107:187-194, 2003
24. Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD: Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 59:787-793, 2002
25. Vermeer SE, den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM: Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 34:392-396, 2003
26. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR: Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 55:1217-1225, 1998
27. Arauz A, Murillo L, Cantu C, Barinagarrementeria F, Higuera J: Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging: risk factors, recurrence, and outcome in 175 consecutive cases. Stroke 34:2453-2458, 2003
28. Hsu LC, Hu HH, Chang CC, Sheng WY, Wang SJ, Wong WJ: Comparison of risk factors for lacunar infarcts and other stroke subtypes. Zhonghua Yi Xue Za Zhi (Taipei) 59:225-231, 1997
29. Revilla M, Obach V, Cervera A, Davalos A, Castillo J, Chamorro A: A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett 324:29-32, 2002
30. Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, Bogousslavsky J, Devuyst G: Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology 62:1558-1562, 2004
31. Sarkar RN, Banerjee S, Basu A: Comparative evaluation of diabetic and non-diabetic stroke: effect of glycaemia on outcome. J Indian Med Assoc 102:551-553, 2004
32. Pirttila T, Jarvenpaa R, Laippala P, Frey H: Brain atrophy on computerized axial tomography scans: interaction of age, diabetes and general morbidity. Gerontology 38:285-291, 1992
33. Longstreth WT Jr, Arnold AM, Manolio TA, Burke GL, Bryan N, Jungreis CA, O'Leary D, Enright PL, Fried L: Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3,301 elderly people: the Cardiovascular Health Study: Collaborative Research Group. Neuroepidemiology 19:30-42, 2000
34. Padovani A, Di Piero V, Bragoni M, Di Biase C, Trasimeni G, Iannili M, Laudani G, Zanette E, Gualdi GF, Lenzi GL: Correlates of leukoaraiosis and ventricular enlargement on magnetic resonance imaging: a study in normal elderly and cerebrovascular patients. Eur J Neurol 4:15-23, 1997
35. Soininen H, Puranen M, Helkala EL, Laakso M, Riekkinen PJ: A computed tomography study in an elderly population. Neurobiol Aging 13:717-721, 1992
36. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, Ryan CM, Jimerson DC, Hennen J, Renshaw PF, Jacobson AM: Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55:326-333, 2006
37. Yousem DM, Tasman WS, Grossman RI: Proliferative retinopathy: absence of white matter lesions at MR imaging. Radiology 179:229-230, 1991
38. Coskun O, Yildiz H, Emre U, Akin U, Ucler S, Ergun U, Tunc T, Inan EL: Leukoaraiosis in stroke patients. Int J Neurosci 113:915-922, 2003
39. Awada A, Omojola MF: Leuko-araiosis and stroke: a case-control study. Acta Neurol Scand 94:415-418, 1996
40. Jorgensen HS, Nakayama H, Raaschou HO, Gam J, Olsen TS: Silent infarction in acute stroke patients: prevalence, localization, risk factors, and clinical significance: the Copenhagen Stroke Study. Stroke 25:97-104, 1994
41. Raiha I, Tarvonen S, Kurki T, Rajala T, Sourander L: Relationship between vascular factors and white matter low attenuation of the brain. Acta Neurol Scand 87:286-289, 1993
42. Adachi T, Kobayashi S, Yamaguchi S: Frequency and pathogenesis of silent subcortical brain infarction in acute first-ever ischemic stroke. Intern Med 41:103-108, 2002
43. Selvetella G, Notte A, Maffei A, Calistri V, Scamardella V, Frati G, Trimarco B, Colonnese C, Lembo G: Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients. Stroke 34:1766-1770, 2003
44. Kawamoto R, Tomita H, Oka Y, Kodama A: Metabolic syndrome as a predictor of ischemic stroke in elderly persons. Intern Med 44:922-927, 2005
45. Geissler A, Frund R, Scholmerich J, Feuerbach S, Zietz B: Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp Clin Endocrinol Diabetes 111:421-427, 2003
46. Kreis R, Ross BD: Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 184:123-130, 1992
47. Kario K, Ishikawa J, Hoshide S, Matsui Y, Morinari M, Eguchi K, Ishikawa S, Shimada K: Diabetic brain damage in hypertension: role of renin-angiotensin system. Hypertension 45:887-893, 2005
48. Ross AJ, Sachdev PS: Magnetic resonance spectroscopy in cognitive research. Brain Res Brain Res Rev 44:83-102, 2004
49. MacLeod KM, Hepburn DA, Deary IJ, Goodwin GM, Dougall N, Ebmeier KP, Frier BM: Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia 37:257-263, 1994
50. Keymeulen B, Jacobs A, de Metz K, de Sadeleer C, Bossuyt A, Somers G: Regional cerebral hypoperfusion in long-term type 1 (insulin-dependent) diabetic patients: relation to hypoglycaemic events. Nucl Med Commun 16:10-16, 1995
51. Quirce R, Carril JM, Jimenez-Bonilla JF, Amado JA, Gutierrez-Mendiguchia C, Banzo I, Blanco I, Uriarte I, Montero A: Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease. Eur J Nucl Med 24:1507-1513, 1997
52. Nagamachi S, Nishikawa T, Ono S, Ageta M, Matsuo T, Jinnouchi S, Hoshi H, Ohnishi T, Futami S, Watanabe K: Regional cerebral blood flow in diabetic patients: evaluation by N-isopropyl-123I-IMP with SPECT. Nucl Med Commun 15:455-460, 1994
53. Rodriguez G, Nobili F, Celestino MA, Francione S, Gulli G, Hassan K, Marenco S, Rosadini G, Cordera R: Regional cerebral blood flow and cerebrovascular reactivity in IDDM. Diabetes Care 16:462-468, 1993
54. Ziegler D, Langen KJ, Herzog H, Kuwert T, Muhlen H, Feinendegen LE, Gries FA: Cerebral glucose metabolism in type 1 diabetic patients. Diabet Med 11:205-209, 1994
55. Biessels GJ, Kappelle LJ: Increased risk of Alzheimer's disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33:1041-1044, 2005
56. Prins ND, van Straaten EC, van Dijk EJ, Simoni M, van Schijndel RA, Vrooman HA, Koudstaal PJ, Scheltens P, Breteler MM, Barkhof F: Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology 62:1533-1539, 2004
57. Meltzer CC, Cantwell MN, Greer PJ, Ben Eliezer D, Smith G, Frank G, Kaye WH, Houck PR, Price JC: Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. J Nucl Med 41:1842-1848, 2000
58. de Leeuw FE, de Groot JC, Bots ML, Witteman JC, Oudkerk M, Hofman A, Van Gijn J, Breteler MM: Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol 247:291-296, 2000
59. de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, Van Gijn J, Breteler MM: Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125:765-772, 2002
60. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM: C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112:900-905, 2005
61. Heijer T, Skoog I, Oudkerk M, de Leeuw FE, de Groot JC, Hofman A, Breteler MM: Association between blood pressure levels over time and brain atrophy in the elderly. Neurobiol Aging 24:307-313, 2003
62. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R: Risk factors for progression of brain atrophy in aging: six-year follow-up of normalsubjects. Neurology 64:1704-1711, 2005
63. Fukuda H, Kitani M: Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke 26:1593-1597, 1995
64. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS: Leukoaraiosis in stroke patients: the Copenhagen Stroke Study. Stroke 26:588-592, 1995
65. Henon H, Godefroy O, Lucas C, Pruvo JP, Leys D: Risk factors and leukoaraiosis in stroke patients. Acta Neurol Scand 94:137-144, 1996
66. Fukuda H, Kitani M: Cigarette smoking is correlated with the periventricular hyperintensity grade of brain magnetic resonance imaging. Stroke 27:645-649, 1996
67. Konemori G: Lipoprotein (a) and other risk factors for cerebral infarction. Hiroshima J Med Sci 44:65-77, 1995
68. Giele JL, Witkamp TD, Mali WP, van der GY: Silent brain infarcts in patients with manifest vascular disease. Stroke 35:742-746, 2004
69. Uehara T, Tabuchi M, Mori E: Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia. Stroke 30:378-382, 1999